Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share (AVDL) Stock Price Up 7.5%

Shares of Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share (NASDAQ:AVDL) rose 7.5% during trading on Friday . The company traded as high as $10.59 and last traded at $10.51. Approximately 631,800 shares changed hands during mid-day trading, an increase of 156% from the average daily volume of 247,122 shares. The stock had previously closed at $9.78.

AVDL has been the subject of a number of recent research reports. BidaskClub upgraded shares of Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share from a “strong sell” rating to a “sell” rating in a report on Thursday, January 4th. Zacks Investment Research upgraded shares of Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share from a “sell” rating to a “hold” rating in a report on Tuesday, November 14th. Finally, Roth Capital set a $14.00 price objective on shares of Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share and gave the company a “buy” rating in a report on Wednesday, January 3rd. One research analyst has rated the stock with a sell rating, one has given a hold rating and two have assigned a buy rating to the stock. The company currently has an average rating of “Hold” and a consensus target price of $21.50.

The firm has a market capitalization of $372.38, a price-to-earnings ratio of 5.45 and a beta of 1.34. The company has a current ratio of 1.53, a quick ratio of 1.47 and a debt-to-equity ratio of 0.01.

Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share (NASDAQ:AVDL) last released its quarterly earnings data on Wednesday, November 8th. The company reported $0.09 EPS for the quarter, beating the Zacks’ consensus estimate of ($0.04) by $0.13. The company had revenue of $39.68 million during the quarter, compared to the consensus estimate of $38.22 million. Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share had a net margin of 44.47% and a return on equity of 33.92%. Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share’s quarterly revenue was up 23.7% on a year-over-year basis. During the same quarter in the prior year, the firm earned ($0.08) EPS. equities analysts anticipate that Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share will post 0.32 earnings per share for the current year.

In other news, CEO Michael S. Anderson purchased 5,000 shares of the business’s stock in a transaction dated Thursday, December 7th. The stock was acquired at an average price of $8.86 per share, for a total transaction of $44,300.00. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Craig R. Stapleton sold 254,265 shares of the firm’s stock in a transaction that occurred on Monday, November 27th. The stock was sold at an average price of $9.35, for a total transaction of $2,377,377.75. Following the sale, the director now owns 253,413 shares of the company’s stock, valued at approximately $2,369,411.55. The disclosure for this sale can be found here. 5.07% of the stock is currently owned by corporate insiders.

Several hedge funds and other institutional investors have recently made changes to their positions in AVDL. Janus Henderson Group PLC acquired a new stake in shares of Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share during the 2nd quarter worth approximately $24,100,000. Stonepine Capital Management LLC increased its holdings in shares of Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share by 31.7% during the 3rd quarter. Stonepine Capital Management LLC now owns 985,210 shares of the company’s stock worth $10,345,000 after buying an additional 237,347 shares during the last quarter. Janney Montgomery Scott LLC acquired a new stake in shares of Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share during the 3rd quarter worth approximately $2,100,000. Boston Partners acquired a new stake in shares of Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share during the 3rd quarter worth approximately $1,868,000. Finally, OxFORD Asset Management LLP increased its holdings in shares of Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share by 62.7% during the 2nd quarter. OxFORD Asset Management LLP now owns 334,881 shares of the company’s stock worth $3,694,000 after buying an additional 129,044 shares during the last quarter. Institutional investors and hedge funds own 67.75% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This piece of content was originally posted by Stock Observer and is owned by of Stock Observer. If you are accessing this piece of content on another domain, it was illegally copied and republished in violation of U.S. and international trademark & copyright law. The legal version of this piece of content can be viewed at https://www.thestockobserver.com/2018/01/12/avadel-pharmaceuticals-plc-american-depositary-shares-each-representing-one-ordinary-share-avdl-stock-price-up-7-5.html.

Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share Company Profile

Avadel Pharmaceuticals plc (NASDAQ: AVDL) is a specialty pharmaceutical company that seeks to commercialize differentiated pharmaceutical products that are safe, effective and easy to take through formulation development, by utilizing its proprietary drug delivery technology and in-licensing / acquiring new products; ultimately, helping patients adhere to their prescribed medical treatment and see better results.

Receive News & Ratings for Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply